Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03954171 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Platino-resistance in Ovarian Cancer

Study acronym: PlatinOv
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv10
  2. Primary and study completion dates: Mar 2030 to Mar 2033v9
  3. 2 versions Re-verified since Aug 2, 2023, no change to tracked fieldsv7-v8
  4. Primary and study completion dates: May 2029 to Mar 2030v6
  5. Re-verified, no change to tracked fieldsv5
Show 3 earlier versionsHide 3 earlier versions
  1. Trial status: Suspended to Recruiting
    • Site details revised
    v4
  2. Trial status: Recruiting to Suspended Sponsor's reason: Context of the Covid-19 pandemic
    • Start date changed from estimate of Jan 2020 to Mar 6, 2020
    • Site details revised
    v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date: May 2019 to Jan 2020
    • Eligibility criteria expanded, about 19 words
    • Site details revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Prospective, monocentric study aiming to identify factors involved in platinum based-chemotherapy resistance in patients with epithelial ovarian cancer (all stages). Patients will receive treatment (platinum based-chemotherapy) according to the standard practices. A prospective database and an associated biological collection will be performed during 5 years: * For each patient: clinical, biological, epidemiological and therapeutic treatment data will be collected during the standard therapeutic care. * Biological samples (blood samples, tumor biopsy specimens and ascites samples) will be collected for all patients. These samples will be collected at the same time as those taken in standard practice (no additional biopsy will be performed for the study). Study participation of each patient will be 5 years.
Trial Details
NCT Number NCT03954171
Lead Sponsor Institut Claudius Regaud
Conditions
(from sponsor)		 Epithelial Ovarian Cancer
Related terms Carcinoma, Ovarian Epithelial
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov